2024-2028年全球免疫沉澱分析法市場

免疫沉澱分析法市場預計在 2023-2028 年期間成長 2.701 億美元，預測期內複合年成長率為 6.01%。

該報告包括對免疫沉澱分析法市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括生物製藥研究和開發的增加、對治療性抗體的需求不斷成長以及對新生兒篩檢測試的日益關注。

研究認為，基因組計劃的興起將成為未來幾年推動免疫沉澱分析法市場成長的關鍵因素之一。此外，臨床試驗的增加以及受託製造廠商和研究組織的擴張將帶來巨大的市場需求。

目錄

第1章執行摘要

• 市場概況

第2章 市場狀況

• 市場生態系統

第3章 市場規模評估

• 市場定義
• 細分市場分析
• 2023 年市場規模
• 2023-2028年市場展望

第4章 市場規模表現

• 2018-2022年全球免疫沉澱分析法市場
• 2018-2022 年最終用戶細分分析
• 2018-2022 年按類型分類的細分市場分析
• 2018-2022 年區域細分分析
• 2018-2022 年國家細分分析

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第 6 章市場區隔：按最終用戶

• 細分市場
• 比較：按最終用戶
• 學術研究院：2023-2028年市場規模及預測
• 合約研究機構：2023-2028年市場規模及預測
• 製藥和生物技術公司：2023-2028 年市場規模和預測
• 市場機會：依最終用戶分類

第7章市場區隔：依類型

• 細分市場
• 比較：按類型
• 染色質免疫沉澱分析法：2023-2028年市場規模及預測
• 個體蛋白質免疫沉澱分析法：2023-2028 年市場規模與預測
• 免疫共沉澱法：2023-2028年市場規模及預測
• RNA免疫沉澱分析法：2023-2028年市場規模與預測
• 市場機會：按類型

第8章 客戶狀況

• 客戶狀況概覽

第9章 地區情勢

• 區域細分
• 區域比較
• 北美：2023-2028 年市場規模與預測
• 歐洲：2023-2028 年市場規模與預測
• 亞洲：2023-2028年市場規模與預測
• 世界其他地區：2023-2028 年市場規模與預測
• 美國：2023-2028 年市場規模與預測
• 英國：2023-2028 年市場規模與預測
• 中國：2023-2028年市場規模及預測
• 德國：2023-2028 年市場規模與預測
• 加拿大：2023-2028 年市場規模與預測
• 市場機會：依地區狀況

第 10 章 促進因素、挑戰與趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第11章 供應商情況

• 概述
• 供應商情況
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• Active Motif Inc.
• Agilent Technologies Inc.
• Becton Dickinson and Company
• Bio Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• Danaher Corp.
• GenScript Biotech Corp.
• JSR Micro Inc.
• Merck KGaA
• OriGene Technologies Inc.
• PerkinElmer Inc
• Proteintech Group Inc.
• Rockland Immunochemicals Inc.
• Santa Cruz Biotechnology Inc.
• Thermo Fisher Scientific Inc.

第13章附錄

The immunoprecipitation market is forecasted to grow by USD 270.1 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the immunoprecipitation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing r and d in biopharmaceuticals, rising demand for therapeutic antibodies, and growing focus on newborn screening tests.

Technavio's immunoprecipitation market is segmented as below:

By End-user

• Academic and research institutes
• Contract research organizations
• Pharmaceutical and biotechnology companies

By Type

• Chromatin immunoprecipitation
• Individual protein immunoprecipitation
• Co-immunoprecipitation
• RNA immunoprecipitation

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising number of genome projects as one of the prime reasons driving the immunoprecipitation market growth during the next few years. Also, increasing clinical trials and growing expansion of contract manufacturing organizations and cros will lead to sizable demand in the market.

The report on the immunoprecipitation market covers the following areas:

• Immunoprecipitation market sizing
• Immunoprecipitation market forecast
• Immunoprecipitation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoprecipitation market vendors that include Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the immunoprecipitation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global immunoprecipitation market 2018 - 2022
• 4.2 End-User Segment Analysis 2018 - 2022
• 4.3 Type Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by End-user

• 6.1 Market segments
• 6.2 Comparison by End-user
• 6.3 Academic and research institutes - Market size and forecast 2023-2028
• 6.4 Contract research organizations - Market size and forecast 2023-2028
• 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• 6.6 Market opportunity by End-user

7 Market Segmentation by Type

• 7.1 Market segments
• 7.2 Comparison by Type
• 7.3 Chromatin immunoprecipitation - Market size and forecast 2023-2028
• 7.4 Individual protein immunoprecipitation - Market size and forecast 2023-2028
• 7.5 Co-immunoprecipitation - Market size and forecast 2023-2028
• 7.6 RNA immunoprecipitation - Market size and forecast 2023-2028
• 7.7 Market opportunity by Type

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 UK - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Active Motif Inc.
• 12.4 Agilent Technologies Inc.
• 12.5 Becton Dickinson and Company
• 12.6 Bio Rad Laboratories Inc.
• 12.7 Cell Signaling Technology Inc.
• 12.8 Danaher Corp.
• 12.9 GenScript Biotech Corp.
• 12.10 JSR Micro Inc.
• 12.11 Merck KGaA
• 12.12 OriGene Technologies Inc.
• 12.13 PerkinElmer Inc
• 12.14 Proteintech Group Inc.
• 12.15 Rockland Immunochemicals Inc.
• 12.16 Santa Cruz Biotechnology Inc.
• 12.17 Thermo Fisher Scientific Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global immunoprecipitation market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Type - Market share 2023-2028 (%)
• Exhibits49: Data Table on Type - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Type
• Exhibits51: Data Table on Comparison by Type
• Exhibits52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Type ($ million)
• Exhibits69: Data Table on Market opportunity by Type ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Active Motif Inc. - Overview
• Exhibits120: Active Motif Inc. - Product / Service
• Exhibits121: Active Motif Inc. - Key offerings
• Exhibits122: Agilent Technologies Inc. - Overview
• Exhibits123: Agilent Technologies Inc. - Business segments
• Exhibits124: Agilent Technologies Inc. - Key news
• Exhibits125: Agilent Technologies Inc. - Key offerings
• Exhibits126: Agilent Technologies Inc. - Segment focus
• Exhibits127: Becton Dickinson and Company - Overview
• Exhibits128: Becton Dickinson and Company - Business segments
• Exhibits129: Becton Dickinson and Company - Key news
• Exhibits130: Becton Dickinson and Company - Key offerings
• Exhibits131: Becton Dickinson and Company - Segment focus
• Exhibits132: Bio Rad Laboratories Inc. - Overview
• Exhibits133: Bio Rad Laboratories Inc. - Business segments
• Exhibits134: Bio Rad Laboratories Inc. - Key news
• Exhibits135: Bio Rad Laboratories Inc. - Key offerings
• Exhibits136: Bio Rad Laboratories Inc. - Segment focus
• Exhibits137: Cell Signaling Technology Inc. - Overview
• Exhibits138: Cell Signaling Technology Inc. - Product / Service
• Exhibits139: Cell Signaling Technology Inc. - Key offerings
• Exhibits140: Danaher Corp. - Overview
• Exhibits141: Danaher Corp. - Business segments
• Exhibits142: Danaher Corp. - Key news
• Exhibits143: Danaher Corp. - Key offerings
• Exhibits144: Danaher Corp. - Segment focus
• Exhibits145: GenScript Biotech Corp. - Overview
• Exhibits146: GenScript Biotech Corp. - Business segments
• Exhibits147: GenScript Biotech Corp. - Key news
• Exhibits148: GenScript Biotech Corp. - Key offerings
• Exhibits149: GenScript Biotech Corp. - Segment focus
• Exhibits150: JSR Micro Inc. - Overview
• Exhibits151: JSR Micro Inc. - Product / Service
• Exhibits152: JSR Micro Inc. - Key offerings
• Exhibits153: Merck KGaA - Overview
• Exhibits154: Merck KGaA - Business segments
• Exhibits155: Merck KGaA - Key news
• Exhibits156: Merck KGaA - Key offerings
• Exhibits157: Merck KGaA - Segment focus
• Exhibits158: OriGene Technologies Inc. - Overview
• Exhibits159: OriGene Technologies Inc. - Product / Service
• Exhibits160: OriGene Technologies Inc. - Key offerings
• Exhibits161: PerkinElmer Inc - Overview
• Exhibits162: PerkinElmer Inc - Business segments
• Exhibits163: PerkinElmer Inc - Key news
• Exhibits164: PerkinElmer Inc - Key offerings
• Exhibits165: PerkinElmer Inc - Segment focus
• Exhibits166: Proteintech Group Inc. - Overview
• Exhibits167: Proteintech Group Inc. - Product / Service
• Exhibits168: Proteintech Group Inc. - Key offerings
• Exhibits169: Rockland Immunochemicals Inc. - Overview
• Exhibits170: Rockland Immunochemicals Inc. - Product / Service
• Exhibits171: Rockland Immunochemicals Inc. - Key offerings
• Exhibits172: Santa Cruz Biotechnology Inc. - Overview
• Exhibits173: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibits174: Santa Cruz Biotechnology Inc. - Key offerings
• Exhibits175: Thermo Fisher Scientific Inc. - Overview
• Exhibits176: Thermo Fisher Scientific Inc. - Business segments
• Exhibits177: Thermo Fisher Scientific Inc. - Key news
• Exhibits178: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits179: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits180: Inclusions checklist
• Exhibits181: Exclusions checklist
• Exhibits182: Currency conversion rates for US$
• Exhibits183: Research methodology
• Exhibits184: Validation techniques employed for market sizing
• Exhibits185: Information sources
• Exhibits186: List of abbreviations